MedPath

To Assess the Safety and Efficacy of the 4 Channel NMES Compensatory Medical Device in Swallowing, Multicenter Study

Not Applicable
Completed
Conditions
Dysphagia
Interventions
Device: 4 channel Electrical Stimulation Device
Registration Number
NCT03670485
Lead Sponsor
Seoul National University Hospital
Brief Summary

This study is a confirmation study to prepare clinical trials to evaluate the safety and effectiveness of 4-channel electric stimulation therapy devices as a newly developed function for the treatment of dysphagia disorders. The purpose of this study is to validate the 4ch NMES device.

Detailed Description

* Design: Prospective study

* Inclusion criteria of patient group: who has a dysphagia symptom and confirmed by video-fluoroscopic swallowing study

* Intervention: applied electrical stimulation by a "Synchronized Electrical Stimulation Device(SESD)"

* Main outcome measures: videofluoroscopic parameters, EQ-5D (EuroQoL-5D) questionnaire, II. M. D Anderson dysphagia inventory

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
51
Inclusion Criteria
  • patient who do not belong to the criteria excluded for subjects aged 19 years or older
  • Patient who is confirmed to be dysphagia by videofluoroscopy
  • Patients who need clinical application of electrical stimulation therapy equipment for dysphagia. ex) stroke, cervical spinal cord injury
  • Those voluntarily agreeing to the clinical trial
Exclusion Criteria
  • Patient who refuse inspection, do not agree
  • Simple "Commend obey", first step is impossible
  • When instructions can not be executed due to dementia, psychiatric disorders, etc.
  • Dysphagia occurs due to respiratory failure, neck surgery, etc.,
  • Pregnant women and lactating women

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Revised sequential activation protocol4 channel Electrical Stimulation DeviceApply 4 channel electrical stimulation device with a revised sequential activation protocol. It sequentially activates Rt. suprahyoid m (ch 1), Lt. suprahyoid m (ch 2), thyrohyoid m (ch 3), sternothyroid m (ch 4) with 4 channel electrical stimulation device.
Primary Outcome Measures
NameTimeMethod
The Modified Barium Swallow Impairment Profile (MBSImP™©)Change from Baseline without stimulation at within 1 weeks with electrical stimulation applied

total score 0 from 55, 55 is worst outcome

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Seoul national university bundang hospital

🇰🇷

Seongnam-si, Bundang, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath